Arch Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2020
February 12, 2021 at 04:25 pm EST
Arch Therapeutics, Inc. announced earnings results for the first quarter ended December 31, 2020. For the first quarter, the company announced operating loss was USD 1.263 million compared to USD 1.619 million a year ago. Net loss was USD 1.154 million compared to USD 1.659 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.